This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Andrew S. Moore – Innovator in Cancer Therapeutics
Introduction
Andrew S. Moore is a distinguished inventor based in Herston, Australia, known for his significant contributions to the field of cancer research. As an innovator, he has focused on developing novel compounds aimed at treating various proliferative disorders, including cancer. His work is crucial to advancing the understanding and treatment of diseases impacted by specific biological mechanisms.
Latest Patents
Andrew S. Moore holds a patent for pharmaceutically active compounds, which play a vital role in cancer treatment. The patent involves compounds of formula I, wherein specific groups are defined that serve as inhibitors of aurora kinase and/or FLT3. This invention extends to the processes for preparing these compounds and their use in creating pharmaceutical compositions aimed at treating proliferative disorders associated with breast cancer and other diseases where aurora kinase and/or FLT3 activity is implicated.
Career Highlights
Currently working with Cancer Research Technology Limited, Andrew has made a name for himself in the pharmaceutical sector. His research and development efforts focus on critical areas of therapeutic innovation, particularly in cancer therapeutics. The potential impact of his patented compounds in clinical applications marks a significant advancement in oncological treatments.
Collaborations
Throughout his career, Andrew has collaborated with notable colleagues such as Julian Blagg and Vassilios Bavetsias. These collaborations reflect his dedication to working alongside other experts in the field, enhancing the scope of research and paving the way for more effective therapeutic options for patients.
Conclusion
In conclusion, Andrew S. Moore exemplifies the spirit of innovation in the pharmaceutical industry. With his inventive prowess in developing compounds for treating cancer, he continues to play a pivotal role in addressing the challenges faced in oncological therapies. As research progresses, the implications of his work are poised to create a meaningful impact on the lives of patients battling proliferative disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile